Archford Capital Strategies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-190
Closed -$11K 669
2018
Q2
$11K Buy
190
+130
+217% +$6.35K ﹤0.01% 420
2018
Q1
$2K Buy
+60
New +$2.27K ﹤0.01% 531
2017
Q1
Sell
-75
Closed -$1K 764
2016
Q4
$1K Hold
75
﹤0.01% 585
2016
Q3
$1K Hold
75
﹤0.01% 610
2016
Q2
$1K Buy
+75
New +$875 ﹤0.01% 666
2016
Q1
Sell
-75
Closed -$2K 549
2015
Q4
$2K Hold
75
﹤0.01% 708
2015
Q3
$2K Buy
+75
New +$2.02K ﹤0.01% 563

Other funds holding TDOC

Archford Capital Strategies's TDOC Position: Q3 2018 in Review

Archford Capital Strategies sold out of Teladoc Health (TDOC) in Q3 2018, closing a stake of 190 shares — an estimated $11K sold.

Archford Capital Strategies first reported a position in TDOC in Q3 2015 and held it in 7 quarters. The position peaked at $11K in Q2 2018. 334 funds tracked by Wall St. Rank hold TDOC as of Q3 2018.

  • Archford Capital Strategies reported no remaining Teladoc Health position as of Q3 2018 after selling out during the quarter.
  • Archford Capital Strategies sold 190 Teladoc Health shares in Q3 2018, an estimated $11K.
  • Archford Capital Strategies first reported a position in Teladoc Health in Q3 2015 and held it in 7 quarters.
  • Archford Capital Strategies's Teladoc Health position peaked at $11K in Q2 2018.
  • 334 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2018.

Based on Archford Capital Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.